Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
513
-
Total 13F shares, excl. options
-
149M
-
Shares change
-
+605K
-
Total reported value, excl. options
-
$12.2B
-
Value change
-
+$77.7M
-
Put/Call ratio
-
0.39
-
Number of buys
-
239
-
Number of sells
-
-260
-
Price
-
$81.63
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2023
607 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2023.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 513 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 149M shares
of 152M outstanding shares and own 98.01% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.4M shares), BlackRock Inc. (16.9M shares), STATE STREET CORP (6.41M shares), BAMCO INC /NY/ (5.38M shares), Select Equity Group, L.P. (4.51M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.07M shares), NEUBERGER BERMAN GROUP LLC (3.78M shares), GEODE CAPITAL MANAGEMENT, LLC (3.54M shares), DF DENT & CO INC (3.28M shares), and AMERIPRISE FINANCIAL INC (3.18M shares).
This table shows the top 513 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.